Another mouse story but -
According to Dr. Stephen Huhn, vice president and head of the central nervous system program at StemCells Inc., "the strong preclinical data we have accumulated to date will enable our transition to a clinical trial, which we plan to initiate in 2011."

http://www.sciencemagnews.com/human-...rd-injury.html